Skip Navigation LinksHome > March 2012 - Volume 55 - Issue 1 > Risk of Malignancy in Sonographically Confirmed Ovarian Tumo...
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e31824970cf
Ovarian Cancer

Risk of Malignancy in Sonographically Confirmed Ovarian Tumors

MILLER, RACHEL WARE MD; UELAND, FREDERICK R. MD

Collapse Box

Abstract

Ovarian cancer is the leading cause of gynecologic cancer death in the United States. Once an ovarian tumor is identified, a pelvic ultrasound is recommended, including tumor volume and tumor structure. Unilocular and simple septate tumors are unlikely to be malignant and when asymptomatic, can be safely followed conservatively without surgery. Complex ovarian tumors are at an increased risk for malignancy and secondary testing is recommended. Secondary testing may include CA125, OVA1, the RMI, ROMA, or the ACOG referral guidelines. When secondary testing indicates that an ovarian tumor is at high risk for malignancy, referral to a gynecologic oncologist is recommended.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.